RUNX3 and neoplasm: Since several reports suggested low RUNX3 expression in GI cancers, our data, adds a new dimension to the biology of RUNX3 and suggests that RUNX3 to function in tumor suppressive manner and emphasizes the need to revisit our understanding of RUNX3 biology in GI cancers.